Header cover image

Household Healthcare Sector

Results

2302

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2302 companies

Arcturus Therapeutics Holdings

Market Cap: US$330.9m

Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.

ARCT

US$12.03

7D

-5.3%

1Y

-68.7%

iTeos Therapeutics

Market Cap: US$327.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.

ITOS

US$8.53

7D

2.2%

1Y

-50.1%

Nano-X Imaging

Market Cap: US$327.4m

Develops a commercial-grade tomographic imaging device with a digital X-ray source.

NNOX

US$5.18

7D

-5.6%

1Y

-39.0%

Alpha Teknova

Market Cap: US$319.0m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

TKNO

US$5.87

7D

-12.6%

1Y

230.7%

Outset Medical

Market Cap: US$318.1m

A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.

OM

US$18.79

7D

-3.7%

1Y

-68.5%

Cidara Therapeutics

Market Cap: US$314.9m

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

CDTX

US$24.00

7D

-10.8%

1Y

103.9%

Varex Imaging

Market Cap: US$312.2m

Designs, manufactures, and sells X-ray imaging components.

VREX

US$7.83

7D

-3.8%

1Y

-47.8%

Abeona Therapeutics

Market Cap: US$311.6m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$6.12

7D

-4.7%

1Y

49.3%

National Research

Market Cap: US$309.7m

Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.

NRC

US$13.64

7D

-1.2%

1Y

-54.7%

Aurora Cannabis

Market Cap: CA$426.4m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

ACB

CA$7.57

7D

2.0%

1Y

-12.0%

Cytek Biosciences

Market Cap: US$306.5m

A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.

CTKB

US$2.57

7D

-3.4%

1Y

-56.7%

EBR Systems

Market Cap: AU$474.2m

Develops implantable systems for wireless tissue stimulation.

EBR

AU$1.11

7D

-9.1%

1Y

4.7%

Cresco Labs

Market Cap: CA$422.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.

CL

CA$0.92

7D

-8.0%

1Y

-63.1%

Cryoport

Market Cap: US$302.8m

Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.

CYRX

US$6.03

7D

-10.5%

1Y

-45.8%

XOMA Royalty

Market Cap: US$297.4m

Operates as a biotech royalty aggregator in the United States and the Asia Pacific.

XOMA

US$24.92

7D

-6.3%

1Y

-2.3%

Canopy Growth

Market Cap: CA$401.8m

Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.

WEED

CA$2.35

7D

-3.3%

1Y

-79.7%

Imricor Medical Systems

Market Cap: AU$449.3m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

IMR

AU$1.66

7D

3.1%

1Y

232.0%

American Oncology Network

Market Cap: US$289.0m

Through its subsidiaries, provides oncology management services in the United States.

AONC

US$6.36

7D

-8.5%

1Y

169.5%

Compass Therapeutics

Market Cap: US$289.0m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

CMPX

US$2.11

7D

0.5%

1Y

37.9%

NervGen Pharma

Market Cap: CA$390.4m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

NGEN

CA$5.58

7D

-7.0%

1Y

179.0%

Heron Therapeutics

Market Cap: US$282.2m

A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.

HRTX

US$1.89

7D

-1.6%

1Y

-44.6%

Phathom Pharmaceuticals

Market Cap: US$280.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

PHAT

US$4.12

7D

-5.9%

1Y

-60.0%

Immutep

Market Cap: AU$430.8m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

IMM

AU$0.29

7D

-1.7%

1Y

-33.0%

Pacific Biosciences of California

Market Cap: US$276.6m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

PACB

US$0.91

7D

-10.8%

1Y

-51.5%

Gossamer Bio

Market Cap: US$272.8m

A clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.

GOSS

US$1.12

7D

-5.1%

1Y

88.4%

Tvardi Therapeutics

Market Cap: US$272.3m

Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.

TVRD

US$33.39

7D

20.4%

1Y

n/a

Candel Therapeutics

Market Cap: US$272.1m

A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.

CADL

US$5.60

7D

-5.2%

1Y

-34.5%

Ocugen

Market Cap: US$271.8m

A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.

OCGN

US$0.96

7D

18.3%

1Y

-44.0%

Sanara MedTech

Market Cap: US$270.1m

A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.

SMTI

US$30.78

7D

-0.8%

1Y

0.8%

Oncology Institute

Market Cap: US$269.5m

An oncology company, provides various medical oncology services in the United States.

TOI

US$3.01

7D

8.3%

1Y

528.4%

Corvus Pharmaceuticals

Market Cap: US$269.1m

A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.

CRVS

US$3.67

7D

-0.3%

1Y

81.7%

Alumis

Market Cap: US$265.2m

A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.

ALMS

US$4.45

7D

-8.8%

1Y

n/a

Entrada Therapeutics

Market Cap: US$264.4m

A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

TRDA

US$7.70

7D

-6.6%

1Y

-52.3%

Terns Pharmaceuticals

Market Cap: US$263.8m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

TERN

US$3.01

7D

-4.4%

1Y

-52.4%

Oceania Healthcare

Market Cap: NZ$441.8m

Owns and operates retirement villages and care centres in New Zealand.

OCA

NZ$0.61

7D

-4.7%

1Y

8.9%

Neuronetics

Market Cap: US$262.6m

Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.

STIM

US$3.97

7D

-7.5%

1Y

90.9%

Page 15 of 64